Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line

Head and Neck Oncology

Volumn 3, Issue 1, 2011, Pages

  Harris, Matthew ^a   Wang, Xing Guo ^a,b   Jiang, Zewei ^a   Goldberg, Gary L ^a   Casadevall, Arturo ^a   Dadachova, Ekaterina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HUBEI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C1P5; MONOCLONAL ANTIBODY C1P5 RE 188; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TARGETING; GENE DOSAGE; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; ISOTOPE LABELING; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RADIOIMMUNOTHERAPY; SQUAMOUS CELL CARCINOMA; ANIMAL; BIOLOGICAL MODEL; CARCINOMA; DRUG SCREENING; HEAD AND NECK TUMOR; IMMUNOLOGY; METHODOLOGY; NUDE MOUSE; PAPILLOMAVIRUS INFECTION; TUMOR CELL LINE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASMS, SQUAMOUS CELL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; RADIOIMMUNOTHERAPY; REPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79751529551     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-3-9     Document Type: Article

References (17)

1. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas. M Hoffmann C Lohrey A Hunziker T Kahn E Schwarz, Oral Oncology 2004 40 520 524 10.1016/j.oraloncology.2003.10.011 15006625 (Pubitemid 38296838)
2. Immortalization of primary human epithelial cells coned cervical carcinoma DNA containing human papillomavirus type E6/E7 open reading frames. P Kaur JK McDougall R Cone, J Gen Virol 1989 70 1261 1266 10.1099/0022-1317-70-5- 1261 2543780 (Pubitemid 19131634)
3. HPV-18 immortalization of human keratinocytes. P Kaur JK McDougall, Virology 1989 173 302 310 10.1016/0042-6822(89)90247-X 2479170 (Pubitemid 19268274)
4. Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. G Percoraro D Morgan V Defendi, Proc Natl Acad Sci USA 1989 86 563 567 10.1073/pnas.86.2.563 2463631 (Pubitemid 19037782)
5. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. KK Ang J Harris R Wheeler R Weber DI Rosenthal PF Nguyen-Tn WH Westra CH Chung RC Jordan C Lu H Kim R Axelrod CC Silverman KP Redmond ML Gillison, N Engl J Med 2010 20530316
6. Targeted therapy of cancer: new prospects for antibodies and immunoconjugates. RM Sharkey DM Goldenberg, CA Cancer J Clin 2006 56 226 243 10.3322/canjclin.56.4.226 16870998 (Pubitemid 44175051)
7. Targeting the virus with radioimmunotherapy in virus-associated cancer. E Dadachova XG Wang A Casadevall, Cancer Biother Radiopharm 2007 22 303 308 10.1089/cbr.2007.344 17651036 (Pubitemid 47067888)
8. Treating cancer as an infectious disease - viral antigens as novel targets for treatment and potential prevention of tumors of viral etiology. XG Wang E Revskaya RA Bryan HD Strickler RD Burk A Casadevall E Dadachova, PLoS ONE 2007 2 114
9. The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)Re-labeled anti-E6 C1P5 antibody in cervical cancer in mice. R Phaeton XG Wang MH Einstein GL Goldberg A Casadevall E Dadachova, Cancer 2010 116 S4 1067 1074 10.1002/cncr.24794 20127955
10. Radioimmunotherapy with antibody to HPV-16 E6 oncoprotein is effective in experimental cervical tumor expressing low levels of E6. R Phaeton M Harris Z Jiang XG Wang MH Einstein GL Goldberg A Casadevall E Dadachova, Cancer Biol Ther 2010 20861673
11. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. TK Hoffmann E Sonkoly U Hauser A van Lierop TL Whiteside JP Klussmann D Hafner P Schuler U Friebe-Hoffmann K Scheckenbach K Erjala R Grénman J Schipper H Bier V Balz, Oral Oncol 2008 44 12 1100 9 10.1016/j.oraloncology.2008.02.006 18487078
12. A new human cell line (FaDu) from a hypopharyngeal carcinoma. SRS Rangan, Cancer 2006 29 117 121 10.1002/1097-0142(197201)29:1<117::AID- CNCR2820290119>3.0.CO;2-R
13. Gene expression profiles in HPV-infected head and neck cancer. NF Schlecht RD Burk L Adrien A Dunne N Kawachi C Sarta Q Chen M Brandwein-Gensler MB Prystowsky G Childs RV Smith TJ Belbin, J Pathol 2007 213 283 93 10.1002/path.2227 17893858 (Pubitemid 350074018)
14. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome dependent degradation independent of their p53- and E6AP-binding capabilities. E Kehmeier H Rühl B Voland MC Stöppler E Androphy H Stöppler, Virology 2002 299 72 87 10.1006/viro.2002.1502 12167343 (Pubitemid 35007513)
15. The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase. KJ Oh A Kalinina J Wang K Nakayama KI Nakayama S Bagchi, J Virol 2004 78 5338 5346 10.1128/JVI.78.10.5338-5346.2004 15113913 (Pubitemid 38581484)
16. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. DJ Sher RI Haddad CM Norris Jr MR Posner LJ Wirth LA Goguen D Annino T Balboni A Allen RB Tishler, Cancer 2010 20572036
17. Identification of cells initiating human melanomas. T Schatton GF Murphy NY Frank K Yamaura AM Waaga-Gasser M Gasser Q Zhan S Jordan LM Duncan C Weishaupt RC Fuhlbrigge TS Kupper MH Sayegh MH Frank, Nature 2008 451 7176 345 9 10.1038/nature06489 18202660